banner

Patenting software and artificial intelligence // IP café: 3 different dates and locations!

Artificial intelligence (AI) is revolutionizing our everyday lives. Only a few decades ago, machines were considered mainly useful for routine and repetitive assignments, now AI-equipped devices are capable of highly complex tasks previously thought exclusive to the human intelligence and capacity. Today, we see ever more ambitious applications of AI which will change the ways in which we work, play, and communicate.

What to expect?

In this IP café we discuss:

  • The ways in which software patent applications are examined at the European Patent Office;
  • How the practice is applied specifically to AI-related inventions;
  • Some of the current talking points.

 

For whom?

  • IP Professionals
  • Representatives from technology transfer offices
  • Inventors
  • Investors
  • Researchers
  • Start-ups
  • Management

 

When and where?

You are welcome as of 4.30 pm for the welcoming reception. Presentations will start around 5.00 pm and will conclude at 6.30 pm, after which you can engage in discussions, and network with colleagues in different fields.

 

 

Event Details

Date:

Thursday, November 7, 2019 - Thursday, December 5, 2019

Location:

This session will be organized three times at De Clercq & Partners' offices across Belgium.

 

Price:

Registration is free of charge but subscription is mandatory. To register, please visit this link.

Language:

English

Organiser(s):

De Clercq & Partners

2019-11-07 16:30:00 2019-12-05 18:30:00 Europe/Brussels Patenting software and artificial intelligence // IP café: 3 different dates and locations! This session will be organized three times at De Clercq &amp; Partners' offices across Belgium.   <p>De Clercq &amp; Partners</p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Event Coordinator

Alternate Text

Stefaan Galle

Event Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?